Trial Profile
A phase I trial of N-003 in healthy volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 03 Dec 2016
Price :
$35
*
At a glance
- Drugs Ambrisentan (Primary)
- Indications Hepatorenal syndrome
- Focus Adverse reactions
- 03 Dec 2016 New trial record